Skip to main content

Industry News

Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.

Biosite Plans Mira Mesa Headquarters

Published 6/29/2003

San Diego-based Biosite is planning to construct a four-building, 350,000-sf corporate headquarters on 17.7 acres recently purchased in Mira Mesa, Calif. Biosite, a maker of rapid diagnostic products, plans to purchase an additional 8.4 acres by year-end 2003. The land, which can accommodate up to 800,000 sf, is in the 130.9 acre Fenton Technology Park. Biosite will relocate in the fourth quarter of 2004 from its nine Sorento Valley buildings where it occupies 190,000 sf. The company plans to expand its employee base from its current 700 up to 1,000 with occupancy of the new headquarters.

Read More

NAIA Develops Olathe Headquarters

Published 6/29/2003

The National Association of Intercollegiate Athletics will develop its new $6-million headquarters on 6.4 acres in Cedar Creek Corporate Park in Olathe, Mo. The architect for the 35,000-sf facility is DLR Group of Overland Park, with Ambassador Construction of Olathe as general contractor. 

Read More

Neoteris Expands with Sunnyvale Relocation

Published 6/26/2003

Internet software maker Neoteris is relocating its headquarters from Mountain View to Sunnyvale, Calif. The new 44,702-sf facility triples Neoteris’ office space and expands available lab space for research and product development.

Read More

E-Loan Consolidates in Pleasanton

Published 6/26/2003

Online lender E-Loan will consolidate its 750-employee work force in 118,000-sf of the Pleasanton Corporate Commons in Pleasanton, Calif. E-Loan has an option to lease an additional 90,000-sf in the building where it will occupy four floors. The facility was one of three built for Charles Schwab Corp.

Read More

VaxGen Opens South San Francisco Facility

Published 6/26/2003

Brisbane, Calif.-based VaxGen has opened an $11-million facility in South San Francisco that will manufacture the company’s anthrax vaccine, AIDS vaccine, and products ranging from smallpox vaccine to monoclonal antibodies. The 17,000-sf facility is adjacent to the company’s research and development operations, and features stainless steel bioprocessors and purifiers. The facility can be easily reconfigured as manufacturing requirements change as much of the equipment is on wheels.

Read More